Treatment of systolic and diastolic heart failure in the elderly

Journal of the American Medical Directors Association

Volumn 7, Issue 1, 2006, Pages 29-36

  Aronow, Wilbert S ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Aldosterone antagonists; Angiotensin converting enzyme inhibitors; Beta blockers; Digoxin; Diuretics; Heart failure; Hydralazine; Isosorbide dinitrate

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CARVEDILOL; CLOPIDOGREL; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FUROSEMIDE; GLYCERYL TRINITRATE; HYDRALAZINE PLUS ISOSORBIDE DINITRATE; HYDROCHLOROTHIAZIDE; LOOP DIURETIC AGENT; LOSARTAN; METOLAZONE; METOPROLOL; NESIRITIDE; NIFEDIPINE; NITRATE; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TRIAMTERENE; UNINDEXED DRUG; VASODILATOR AGENT;

AGED; ANGIONEUROTIC EDEMA; CLINICAL PROTOCOL; CLINICAL TRIAL; COMORBIDITY; COUGHING; DEFIBRILLATOR; DEHYDRATION; DIASTOLIC BLOOD PRESSURE; DIGITALIS INTOXICATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG ERUPTION; DRUG TOLERABILITY; FLUID RETENTION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PACING; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPOKALEMIA; HYPOMAGNESEMIA; HYPOTENSION; KIDNEY FAILURE; LUNG EDEMA; PALLIATIVE THERAPY; PATIENT MONITORING; PERIPHERAL EDEMA; REVIEW; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TASTE DISORDER; UREMIA;

EID: 32444449171     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2005.07.008     Document Type: Article

References (67)

1. S.A. Hunt D.W. Baker M.H. Chin et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). Developed in collaboration with the International Society for Heart and Lung Transplantation. Endorsed by the Heart Failure Society of America J Am Coll Cardiol 38 2001 2101-2113
2. W.S. Aronow C. Ahn H. Gutstein Prevalence and incidence of cardiovascular disease in 1160 men and 2464 older women in a long-term health care facility J Gerontol Med Sci 57A 2002 M45-M46
3. W.S. Aronow C. Ahn I. Kronzon Normal left ventricular ejection fraction in older persons with congestive heart failure Chest 113 1998 867-869
4. W.S. Aronow C. Ahn I. Kronzon Comparison of incidences of congestive heart failure in older African-Americans, Hispanics, and whites Am J Cardiol 84 1999 611-612
5. W.S. Aronow C. Ahn I. Kronzon Prognosis of congestive heart failure after prior myocardial infarction in older men and women with abnormal versus normal left ventricular ejection fraction Am J Cardiol 85 2000 1382-1384
6. W.S. Aronow C. Ahn I. Kronzon Prognosis of congestive heart failure after prior myocardial infarction in older persons with atrial fibrillation versus sinus rhythm Am J Cardiol 87 2001 224-225
7. W.S. Aronow What is the appropriate treatment of hypertension in elders? J Gerontol Med Sci 57A 2002 M483-M486
8. W.S. Aronow Hypercholesterolemia. The evidence supports the use of statins Geriatrics 58 2003 18-32
9. W.S. Aronow Exercise therapy for older persons with cardiovascular disease Am J Geriatr Cardiol 10 2001 245-252
10. M.W. Rich V. Beckham C. Wittenberg et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure N Engl J Med 333 1995 1190-1195
11. M.W. Rich Heart failure in the 21st century A cardiogeriatric syndrome J Gerontol Med Sci 56A 2001 M88-M96
12. G.W. Neuberg A.B. Miller C.M. O'Connor et al.Diuretic resistance predicts mortality in patients with advanced heart failure Am Heart J 144 2002 31-38
13. The CONSENSUS Trial Study Group Effect of enalapril on mortality in severe congestive heart failure results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) N Engl J Med 316 1987 1429-1435
14. J. Cohn G. Johnson S. Ziesche et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure N Engl J Med 325 1991 303-310
15. The SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 1991 293-302
16. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure Lancet 342 1993 821-828
17. M.A. Pfeffer E. Braunwald L.A. Moyeet al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial N Engl J Med 327 1992 669-677
18. L. Kober C. Torp-Pedersen J.E. Carlsen et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 333 1995 1670-1676
19. W.S. Aronow C. Ahn I. Kronzon Effect of beta blockers alone, of angiotensin-converting enzyme inhibitors alone, and of beta blockers plus angiotensin-converting enzyme inhibitors on new coronary events and on congestive heart failure in older persons with healed myocardial infarcts and asymptomatic left ventricular systolic dysfunction Am J Cardiol 88 2001 1298-1300
20. W.S. Aronow I. Kronzon Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction Am J Cardiol 71 1993 602-604
21. E.F. Philbin T.A. Rocco Jr N.W. Lindenmuth et al. Systolic versus diastolic heart failure in community practice Clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors Am J Med 109 2000 605-613
22. M. Packer P.A. Poole-Wilson P.W. Armstrong et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure Circulation 100 1999 2312-2318
23. Y.-T. Chen M.J. Radford H.M. Krumholz Aspirin and the treatment of heart failure in the elderly [abstract] J Am Coll Cardiol 35 2000 541A
24. B.M. Brenner M.E. Cooper D. de Zeeuw et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy N Engl J Med 345 2001 861-869
25. L.H. Lindholm H. Ibsen B. Dahlof et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE) A randomised trial against atenolol Lancet 359 2002 1004-1010
26. B. Pitt P.A. Poole-Wilson R. Segal et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure Randomised trial-the Losartan Heart Failure Survival Study ELITE II Lancet 355 2000 1582-1587
27. J.N. Cohn G. Tognoni Valsartan Heart Failure Trial Investigators A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure N Engl J Med 345 2001 1667-1675
28. M.A. Pfeffer J.J.V. McMurray E.J. Velazquez et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both N Engl J Med 349 2003 1893-1906
29. C.B. Granger J.J.V. McMurray S. Yusuf et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors The CHARM-Alternative trial Lancet 362 2003 772-776
30. S. Yusuf M.A. Pfeffer K. Swedberg et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction The CHARM-Preserved trial Lancet 362 2003 777-781
31. M. Packer M.R. Bristow J.N. et al. Cohn The effect of carvedilol on morbidity and mortality in patients with chronic heart failure N Engl J Med 334 1996 1349-1355
32. CIBIS-II Investigators and Committees The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II) A randomised trial Lancet 353 1999 9-13
33. MERIT-HF Study Group Effect of metoprolol CR/XL in chronic heart failure Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet 353 1999 2001-2007
34. M. Packer A.J.S. Coats M.B. et al. Fowler Effect of carvedilol on survival in chronic heart failure N Engl J Med 344 2001 651-658
35. W.S. Aronow C. Ahn I. Kronzon Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction ≥40% treated with diuretics plus angiotensin-converting-enzyme inhibitors Am J Cardiol 80 1997 207-209
36. L. Moye M. Pfeffer SAVE Investigators Additional beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study J Am Coll Cardiol 29 1997 229-236
37. Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology: W. J. Remme and K. Swedberg (Co-Chairmen). Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22:1527-1560.
38. B. Pitt F. Zannad W.J. Remme et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure N Engl J Med 341 1999 709-717
39. B. Pitt W. Remme F. Zannad et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 2003 1309-1321
40. J.N. Cohn D.G. Archibald S. Ziesche et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure Results of a Veterans Administration Cooperative Study N Engl J Med 314 1986 1547-1552
41. Veterans Administration Cooperative Study Group J.N. Cohn G. Johnson Heart failure with normal ejection fraction. The V-HeFT Study Circulation 81 suppl III 1990 III-48-III-53
42. A.L. Taylor S. Ziesche C. Yancy et al. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure N Engl J Med 351 2004 2049-2057
43. W.S. Aronow Echocardiography should be performed in all elderly patients with congestive heart failure J Am Geriatr Soc 42 1994 1300-1302
44. The Digitalis Investigation Group The effect of digoxin on mortality and morbidity in patients with heart failure N Engl J Med 336 1997 525-533
45. M.W. Rich F. McSherry W.O. Williford et al. Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure the DIG Study J Am Coll Cardiol 38 2001 806-813
46. S.S. Rathore Y. Wang H.M. Krumholz Sex-based differences in the effect of digoxin for the treatment of heart failure N Engl J Med 347 2002 1403-1411
47. S.S. Rathore J.P. Curtis Y. Wang et al. Association of serum digoxin concentration and outcomes in patients with heart failure JAMA 289 2003 871-878
48. Ahmed A, Aronow WS, Fleg JL. Predictors of mortality and hospitalization in women with heart failure in the Digitalis Investigation Group trial. Am J Therap. In press.
49. Ahmed A, Aronow WS, Fleg JL. Higher New York Heart Association classes and increased mortality and hospitalization in heart failure patients with preserved left ventricular function. Am Heart J. In press.
50. W.S. Aronow Digoxin or angiotensin converting enzyme inhibitors for congestive heart failure in geriatric patients. Which is the preferred treatment? Drugs Aging 1 1991 98-103
51. U. Elkayam J. Amin A. Mehra et al. A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure Circulation 82 1990 1954-1961
52. The Multicenter Diltiazem Postinfarction Trial Research Group The effect of diltiazem on mortality and reinfarction after myocardial infarction N Engl J Med 319 1988 385-392
53. R.E. Goldstein S.J. Boccuzzi D. Cruess S. Nattel Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction Circulation 83 1991 52-60
54. M. Packer C.M. O'Connor J.K. Ghali et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure N Engl J Med 335 1996 1107-1114
55. J.N. Cohn S. Ziesche R. Smith et al. Effect of the calcium antagonist felodipine as suplementary vasodilator therapy in patients with chronic heart failure treated with enalapril. V-HeFT III Circulation 96 1997 856-863
56. J.F. Setaro B.L. Zaret D.S. Schulman et al. Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance Am J Cardiol 66 1990 981-986
57. W.S. Aronow CRT plus ICD in congestive heart failure. Use of cardiac resynchronization therapy and an implantable cardioverter-defibrillator in heart failure patients with abnormal left ventricular dysfunction Geriatrics 60 2005 24-28
58. J.G.F. Cleland J.-C. Daubert E. Erdmann et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539-1549
59. G.H. Bardy K.L. Lee D.B. Mark et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225-237
60. C.M. O'Connor W.A. Gattis B.F. Uretsky et al. Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure insights from the Flolan International Randomized Survival Trial (FIRST) Am Heart J 138 2000 78-86
61. Publication Committee for the VMAC Investigators Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure. A randomized controlled trial JAMA 287 2002 1531-1540
62. J.D. Sackner-Bernstein M. Kowalski M. Fox K. Aaronson Short-term risk of death after treatment with nesiritide for decompensated heart failure. A pooled analysis of randomized controlled trials JAMA 293 2005 1900-1905
63. S. De Geest E. Steeman M.E. Leventhal et al. Complexity in comparing for an ageing heart failure population concomitant chronic conditions and age-related impairments Eur J Cardiovasc Nurs 3 2004 263-270
64. J. Lindenfeld Prevalence of anemia and effects on mortality in patients with heart failure Am Heart J 149 2005 391-401
65. C.M. Felker K.F. Adams W.A. Gattis C.M. O'Connor Anemia as a risk factor and therapeutic target in heart failure J Am Coll Cardiol 44 2004 959-966
66. W.S. Aronow Treatment of heart failure in older persons. Dilemmas with coexisting conditions: Diabetes mellitus, chronic obstructive pulmonary disease, and arthritis Congest Heart Fail 9 2003 142-147
67. W.S. Aronow Dizziness and syncope W.R. Hazzard J.P. Blass W.H. Ettinger Jr J.B. Halter J.G. Ouslander Principles of Geriatric Medicine and Gerontology 4th ed. 1998 McGraw-Hill Inc New York 1519-1534